• Miraculins Inc., of Winnipeg, Manitoba, reported the final close of a $1 .032 million private placement offering. The second close under the offering generated gross proceeds of $602,000 from the sale of 10,033,333 units at $0.06 per unit. Each unit is comprised of one common share of the company and one-half of one share purchase warrant. Each whole warrant entitles the holder to purchase one share at $0.10 for a period of 12 months from the date the warrant is issued.

• Tekmira Pharmaceuticals Corp., of Vancouver, British Columbia, closed the full overallotment option to purchase an additional 562,500 shares at a price of $8 per share granted to the underwriters in connection with Tekmira’s previously completed public offering of common stock, increasing the total gross proceeds to $34.5 million. Stifel acted as the sole book-running manager for the offering. Maxim Group LLC acted as co-manager.